Stocktoria
IOVANCE BIOTHERAPEUTICS, INC. IOVA
IOVANCE BIOTHERAPEUTICS, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $263.5M | $164.1M | $1.2M | — | — | — | — | $0 | $0 | $0 |
| R&D expense | $300.3M | $276.2M | $333.2M | $294.8M | $259.0M | $201.7M | $166.0M | $99.8M | $71.6M | $26.9M |
| Operating income | -$403.4M | -$395.3M | -$460.6M | -$398.9M | -$342.7M | -$261.9M | -$206.9M | -$128.3M | -$92.9M | -$53.6M |
| Income tax | -$2.1M | -$2.8M | -$3.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$391.0M | -$372.2M | -$444.0M | -$395.9M | -$342.3M | -$259.6M | -$197.6M | -$123.6M | -$92.1M | -$52.9M |
| EPS (diluted) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | — | — | — |
| Operating cash flow | -$302.4M | -$353.0M | -$361.8M | -$292.8M | -$227.9M | -$205.1M | -$158.9M | -$101.2M | -$78.7M | -$32.7M |
| Free cash flow | -$336.2M | -$364.0M | -$384.1M | -$313.2M | -$265.5M | -$251.9M | -$165.8M | -$102.4M | -$79.7M | -$34.2M |
| Cash & equivalents | $163.1M | $115.7M | $114.9M | $231.7M | $78.2M | $67.3M | $14.0M | $82.2M | $145.4M | $106.7M |
| Inventory | $51.7M | $51.5M | $10.4M | — | — | — | — | — | — | — |
| Total assets | $913.2M | $910.4M | $780.4M | $664.0M | $777.3M | $768.5M | $344.7M | $480.8M | $155.4M | $171.9M |
| Total liabilities | $214.6M | $200.0M | $195.7M | $164.3M | $155.7M | $112.0M | $45.7M | $14.6M | $9.9M | — |
| Shareholders' equity | $698.6M | $710.4M | $584.6M | $499.6M | $621.7M | $656.5M | $299.0M | $466.2M | $145.5M | $166.9M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +60.6% | +13699.0% | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.